NL7808337A - In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat. - Google Patents

In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat.

Info

Publication number
NL7808337A
NL7808337A NL787808337A NL7808337A NL7808337A NL 7808337 A NL7808337 A NL 7808337A NL 787808337 A NL787808337 A NL 787808337A NL 7808337 A NL7808337 A NL 7808337A NL 7808337 A NL7808337 A NL 7808337A
Authority
NL
Netherlands
Prior art keywords
pharmacecutical
preparation
cell wall
wall sketch
sketch containing
Prior art date
Application number
NL787808337A
Other languages
English (en)
Dutch (nl)
Original Assignee
Yamamura Yuichi
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Yamamura Yuichi filed Critical Yamamura Yuichi
Publication of NL7808337A publication Critical patent/NL7808337A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55583—Polysaccharides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55588—Adjuvants of undefined constitution
    • A61K2039/55594—Adjuvants of undefined constitution from bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Mycology (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
NL787808337A 1977-08-09 1978-08-09 In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat. NL7808337A (nl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP9587177A JPS5428813A (en) 1977-08-09 1977-08-09 Solid preparation containing cell membrane extract substance used as suspension when using same

Publications (1)

Publication Number Publication Date
NL7808337A true NL7808337A (nl) 1979-02-13

Family

ID=14149407

Family Applications (1)

Application Number Title Priority Date Filing Date
NL787808337A NL7808337A (nl) 1977-08-09 1978-08-09 In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat.

Country Status (15)

Country Link
US (1) US4543253A (xx)
JP (1) JPS5428813A (xx)
AU (1) AU526788B2 (xx)
BE (1) BE869610A (xx)
CA (1) CA1118348A (xx)
CH (1) CH643459A5 (xx)
DE (1) DE2834893A1 (xx)
DK (1) DK153443C (xx)
FI (1) FI65370C (xx)
FR (1) FR2399844A1 (xx)
GB (1) GB2002229B (xx)
HU (1) HU179726B (xx)
IT (1) IT1098381B (xx)
NL (1) NL7808337A (xx)
SE (1) SE447629B (xx)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1206416A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
CA1206415A (en) * 1982-06-30 1986-06-24 John L. Cantrell Pyridine soluble extract of a microorganism
US4806350A (en) * 1986-04-18 1989-02-21 Norden Laboratories, Inc. Vaccine formulation
DD273198A5 (de) * 1986-06-09 1989-11-08 �������@�������k���Kk�� Verfahren zur herstellung eines modifikationsmittels
DE3727987A1 (de) * 1987-08-21 1989-03-02 Sleytr Uwe B Pharmazeutische struktur
US6090385A (en) * 1993-12-10 2000-07-18 Maes; Hubert Method of treating cancer
CN1230184C (zh) * 1998-07-16 2005-12-07 东市郎 以细菌的菌体成分为有效成分的癌免疫治疗用制剂
US20050250175A1 (en) * 2002-08-02 2005-11-10 Takehiko Nomura Bacterial cell wall skeleton component preparaion
EP1741438A4 (en) * 2004-04-22 2009-08-26 Dainippon Sumitomo Pharma Co PHARMACEUTICAL PREPARATION CONTAINING SKELETAL COMPONENT OF BACTERIAL CELL WALL
CN115300490B (zh) * 2021-05-07 2024-04-16 安徽远望乐桓药业有限公司 包含角鲨烯和甘露醇的药物组合物及其用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3185623A (en) * 1960-05-31 1965-05-25 Smith Fred Preservation of animal semen
US3177117A (en) * 1961-12-26 1965-04-06 Joseph F Saunders Process for freezing blood
FR2268531B1 (xx) * 1974-04-25 1978-07-21 Anvar
JPS5132794A (en) * 1974-06-20 1976-03-19 Anvar Koshuyokoirusu oyobi ajubantokatsuseiojusuru maikobakuteriumufurakushonnoseiseiho
FR2345158A1 (fr) * 1976-03-26 1977-10-21 Anvar Agents mitogenes, provenant notamment de peptidoglycanes bacteriens
FR2345159A2 (fr) * 1976-03-26 1977-10-21 Anvar Agents solubles dans l'eau ayant des proprietes mitogenes et/ou immuno-stimulantes, obtenus a partir de cellules de nocardia, et leurs procedes de preparation

Also Published As

Publication number Publication date
SE447629B (sv) 1986-12-01
FI782442A (fi) 1979-02-10
GB2002229A (en) 1979-02-21
FR2399844A1 (fr) 1979-03-09
FR2399844B1 (xx) 1982-08-20
SE7808414L (sv) 1979-02-10
DK153443B (da) 1988-07-18
HU179726B (en) 1982-11-29
JPS5428813A (en) 1979-03-03
US4543253A (en) 1985-09-24
DK352578A (da) 1979-02-10
IT1098381B (it) 1985-09-07
CH643459A5 (de) 1984-06-15
DK153443C (da) 1988-12-05
FI65370C (fi) 1984-05-10
JPS631291B2 (xx) 1988-01-12
CA1118348A (en) 1982-02-16
IT7826609A0 (it) 1978-08-08
AU526788B2 (en) 1983-02-03
BE869610A (fr) 1979-02-08
GB2002229B (en) 1982-05-26
DE2834893C2 (xx) 1987-08-27
FI65370B (fi) 1984-01-31
AU3879178A (en) 1980-02-14
DE2834893A1 (de) 1979-02-22

Similar Documents

Publication Publication Date Title
NL7802373A (nl) Membraancel.
IT1101504B (it) Percettore elettrochimico di gas
NL7708581A (nl) Elektrolysecel.
NL170648C (nl) Elektrolysecel.
NL7807436A (nl) Elektrolysecel.
NL7702327A (nl) Katalyse.
NL7812307A (nl) Lithium-jodiumcel.
NL7807239A (nl) Lithium-jodiumcel.
NL7714464A (nl) Poreuze elektrode.
NL7811958A (nl) Cel.
NL7809899A (nl) Geheugencel.
NL7802371A (nl) Elektrolytische cel.
NL7706998A (nl) Poreuze elektrode.
NL184810B (nl) Mengkolf.
NL7808337A (nl) In vaste vorm gebracht, celwandskelet bevattend farma- ceutisch preparaat.
NL7806896A (nl) Elektrolytische cel.
NL183469C (nl) Elektrolysecel.
NL7811502A (nl) Elektrolytische reductiecellen.
NL7514842A (nl) Elektrolysecel.
NL7804956A (nl) Waterstof.
NL7805379A (nl) Vorm.
NL7712435A (nl) Electrolysecel.
NL7810918A (nl) Lithium-jodiumcel.
NL186420C (nl) Poreus orgaan voor elektrolytruimten.
SE7805116L (sv) Rorkvarn, speciellt kulkvarn

Legal Events

Date Code Title Description
A85 Still pending on 85-01-01
BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
BV The patent application has lapsed